Scarica l'app Stockscreener
4.09
3.31%
-0.14
Precedente Chiudi:
$4.23
Aprire:
$4.18
Volume 24 ore:
335.82K
Relative Volume:
0.36
Capitalizzazione di mercato:
$525.13M
Reddito:
$201.49M
Utile/perdita netta:
$-66.54M
Rapporto P/E:
-7.8699
EPS:
-0.5197
Flusso di cassa netto:
$-8.88M
1 W Prestazione:
-7.26%
1M Prestazione:
-6.19%
6M Prestazione:
-0.97%
1 anno Prestazione:
-4.44%
Intervallo 1D:
$4.08
$4.2068
Intervallo di 1 settimana:
$4.08
$4.485
Portata 52W:
$2.37
$6.18
Cytek Biosciences Inc Stock (CTKB) Company Profile
Nome
Cytek Biosciences Inc
Settore
Industria
Telefono
(877) 922-9835
Indirizzo
47215 LAKEVIEW BOULEVARD, FREMONT
Compare CTKB vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
4.085 | 543.77M | 201.49M | -66.54M | -8.88M | -0.5197 |
|
ABT
Abbott Laboratories
|
110.17 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
343.81 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
88.94 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
68.82 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
84.61 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-02 | Ripresa | Morgan Stanley | Equal-Weight |
| 2025-05-09 | Downgrade | TD Cowen | Buy → Hold |
| 2025-01-31 | Downgrade | Goldman | Buy → Sell |
| 2023-12-14 | Iniziato | Stephens | Overweight |
| 2023-07-19 | Iniziato | Raymond James | Mkt Perform |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
Mostra tutto
Cytek Biosciences Inc Borsa (CTKB) Ultime notizie
Cytek Biosciences expands global reach with one year of Singapore operations - Traders Union
Cytek Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact - Bitget
Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact - Weekly Voice
Cytek Biosciences Highlights Aurora Evo, Recurring Revenue Growth and 2026 Outlook at TD Cowen Conference - Yahoo Finance
How The Cytek Biosciences (CTKB) Story Is Shifting With New Targets And 2026 Guidance - Yahoo Finance
Cytek Biosciences Balances Growth With Margin Strain - TipRanks
Royce & Associates LP Increases Holdings in Cytek Biosciences, Inc. $CTKB - MarketBeat
Cytek Biosciences, Inc. (NASDAQ:CTKB) Receives $5.50 Average PT from Brokerages - Defense World
CTKB SEC FilingsCytek Biosciences, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Cytek Biosciences at TD Cowen Health Care: Strategic Growth Insights By Investing.com - Investing.com Canada
Buyback Watch: What is the Moat Score of Cytek Biosciences IncStop Loss & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
CTKB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Cytek Biosciences outlines cell sorting breakthroughs in webinar - Traders Union
Cytek Biosciences, Inc. (NASDAQ:CTKB) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Cytek Biosciences, Inc. (NASDAQ:CTKB) Q4 2025 Earnings Call Transcript - Insider Monkey
Cytek Biosciences (NASDAQ:CTKB) Announces Quarterly Earnings Results, Misses Estimates By $0.36 EPS - MarketBeat
Earnings call transcript: Cytek Biosciences Q4 2025 sees record revenue, EPS miss - Investing.com South Africa
Cytek (CTKB) Q4 2025 Earnings Call Transcript - The Globe and Mail
Cytek Biosciences, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Cytek Biosciences, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:CTKB) 2026-02-27 - Seeking Alpha
Cytek Biosciences (CTKB) Q4 EPS Swing To Loss Reinforces Margin Concerns - Sahm
Cytek Biosciences earnings missed by $0.32, revenue topped estimates - Investing.com Canada
Cytek Biosciences Q4 Earnings Call Highlights - Yahoo Finance
Earnings Call Summary | Cytek Biosciences(CTKB.US) Q4 2025 Earnings Conference - 富途牛牛
Cytek Biosciences, Inc. (CTKB) Reports Q4 Loss, Tops Revenue Estimates - Nasdaq
Cytek Biosciences Inc (NASDAQ:CTKB) Reports Q4 2025 Revenue Beat and Mixed Earnings - ChartMill
Cytek Biosciences Inc. (CTKB) Stock Falls on Q4 2025 Earnings - Quiver Quantitative
Cytek Biosciences (CTKB) swings to deeper 2025 loss with soft 2026 growth outlook - Stock Titan
Cytek Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results - Quiver Quantitative
Cytek Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook - Yahoo Finance
Cytek Biosciences, Inc. (CTKB) Stock Analysis: Exploring a Potential 37% Upside Amid Challenging Valuations - DirectorsTalk Interviews
Aug Chart Watch: Is Cytek Biosciences Inc stock overvalued or fairly priced2025 Pullback Review & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
[Form 4] Cytek Biosciences, Inc. Insider Trading Activity - Stock Titan
Cytek Biosciences (CTKB) Expected to Announce Earnings on Thursday - Defense World
Cytek Biosciences to participate at the TD Cowen 46th Annual Health Care Conference - The Manila Times
Live March 4 Cytek Biosciences talk at TD Cowen health care conference - Stock Titan
CTKB Should I Buy - Intellectia AI
Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Share Price Is Still Matching Investor Opinion Despite 27% Slump - simplywall.st
Cytek Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 - The Manila Times
Cytek Biosciences, Inc. (CTKB): Investor Outlook On A Promising 37.61% Upside Potential - DirectorsTalk Interviews
Is Cytek Biosciences Inc. in a long term uptrendJuly 2025 Weekly Recap & Long Hold Capital Preservation Plans - mfd.ru
Cytek Biosciences Stock (CTKB) Opinions on Preliminary Q4 and FY2025 Revenue Results - Quiver Quantitative
What are Cytek Biosciences Inc.’s technical support levels2025 Investor Takeaways & Expert Curated Trade Setup Alerts - mfd.ru
Can Cytek Biosciences Inc. stock hit analyst price targets2025 Market WrapUp & Real-Time Buy Signal Alerts - mfd.ru
New York State Common Retirement Fund Has $1.15 Million Holdings in Cytek Biosciences, Inc. $CTKB - MarketBeat
Why Cytek Biosciences Inc. stock is trending among retail tradersPortfolio Update Summary & AI Enhanced Market Trend Forecasts - mfd.ru
What You Can Learn From Cytek Biosciences, Inc.'s (NASDAQ:CTKB) P/S - 富途牛牛
Cytek Biosciences, Inc. (NASDAQ:CTKB) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Brown Capital Management LLC Has $17.20 Million Position in Cytek Biosciences, Inc. $CTKB - MarketBeat
Cytek Biosciences (NASDAQ:CTKB) Trading Up 3.2% – Should You Buy? - Defense World
Cytek Biosciences (NASDAQ:CTKB) Trading Up 3.2%Should You Buy? - MarketBeat
Cytek Biosciences Inc Azioni (CTKB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.61%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):